XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Net revenues
 9 Months Ended
Oct. 01, 2023
Revenue from Contract with Customer [Abstract]  
Net revenues Net revenuesWe primarily generate revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when our products are shipped from the manufacturing or distribution facility. For our Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and we have an enforceable right to payment to the extent that performance has been completed. We market and sell products through our direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers, which constituted 87%, 11% and 2% of consolidated net revenues, respectively, for the nine months ended October 1, 2023. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice.
The following table disaggregates revenue by global product category for the three and nine months ended October 1, 2023 and September 25, 2022.
Three Months EndedNine Months Ended
October 1, 2023September 25, 2022October 1, 2023September 25, 2022
Vascular access$169,919 $167,147 $521,356 $497,188 
Anesthesia97,612 97,608 291,786 289,260 
Interventional134,089 108,738 375,766 319,939 
Surgical112,805 93,124 317,781 282,468 
Interventional urology73,622 78,969 226,819 233,682 
OEM82,309 71,288 243,434 198,947 
Other (1)
76,033 69,914 223,638 211,561 
Net revenues (2)
$746,389 $686,788 $2,200,580 $2,033,045 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).
(2)    The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments includes net revenues from each of the non-OEM product categories listed above.